Abvc Biopharma trades -0.67 percent lower on Monday 26th of October
ABVC Biopharma trades near $1.06, with a $27 M cap and 200‑day SMA at $1.28. Learn how its biotech focus on oncology, hematology, and ophthalmology impacts investors.
- ABVC BIOPHARMA INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read